The following is an archive of papers published by the CCGMC since its establishment in 2020. It also includes any publications that have referenced the work of the Consortium.
Freeman, V., Hughes, S., Carle, C., Campbell, D., Egger, S., Hui, H., Yap, S., Deandrea, S., Caruana, M., Onyeka, T., IJzerman, M., Ginsburg, O., Bray, F., Sullivan, R., Aggarwal, A., Peacock, S., Chan, K., Hanna, T., Soerjomataram, I., O’Donnell, D., Steinberg, J., Canfell, K. (2022). Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. Journal of Cancer Policy. https://doi.org/10.1016/j.jcpo.2022.100340
Carle, C., Hughes, S., Freeman, V., Campbell, D., Egger, S., Hui, H., Yap, S., Deandrea, S., Caruana, M., Onyeka, T., IJzerman, M., Ginsburg, O., Bray, F., Sullivan, R., Aggarwal, A., Peacock, S., Chan, K., Hanna, T., Soerjomataram, I., O’Donnell, D., Steinberg, J., Canfell, K. (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: a systematic review of the early evidence. Journal of Cancer Policy. https://doi.org/10.1016/j.jcpo.2022.100338
Sarich, P., Cabasag, CJ., Liebermann, E., Vaneckova, P., Carle, C., Hughes, S., Egger, S., O’Connell, D., Weber, M., Mafra da Costa, A., Caruana, M., Bray, F., Canfell, K., Ginsburg, O., Steinberg, J., Soerjomataram, I.Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. eClinMedicine. https://doi.org/10.1016/j.eclinm.2022.101375
Soerjomataram, I., Bray, F., Lansdorp-Volgelaar, I., Ginsburg, O., Rahal, R., Sullivan, R., Canfell, K. (2022). COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies. Journal of Cancer Policy. https://doi.org/10.1016/j.jcpo.2022.100328
van Wifferen, F., de Jonge, L., Worthington, J., Greuter, M. J. E., Lew, J.-B., Nadeau, C., van den Puttelaar, R., Feletto, E., Yong, J. H. E., Lansdorp-Vogelaar, I., Canfell, K., & Coupé, V. M. H. (2021). Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study. Journal of Medical Screening. https://doi.org/10.1177/09691413211056777
Figueroa JD, Gray E, Pashayan N, et al.(2021) The impact of the Covid-19 pandemic on breast cancer early detection and screening. Preventive Medicine. https://doi.org/10.1016/j.ypmed.2021.106585
Smith MA, Burger EA, Castanon A, de Kok IMCM, Hanley SJB, Rebolj M, Hall MT, Jansen EEL, Killen J, O’Farrell X, Kim JJ, Canfell K. Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis. Preventive Medicine. https://doi.org/10.1016/j.ypmed.2021.106623
Castanon, A., Rebolj, M., Burger, EA., de Kok, I., Smith, MA., Hanley, S., Carozzi, FM., Peacock, S., O’Mahony, JF (2021). Cervical screening during the COVID-19 pandemic: optimising recovery strategies. The Lancet Public Health. https://doi.org/10.1016/S2468-2667(21)00078-5
de Jonge, L., Worthington, J., van Wifferen, F., Iragorri, N., FP Peterse, E., & Lew, JB. et al. (2021). Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. The Lancet Gastroenterology & Hepatology. http://doi.org/10.1016/S2468-1253(21)00003-0
Ginsburg O., Basu P., Kapambwe S., & Canfell K.(2021) Eliminating cervical cancer in the COVID-19 era. Nature Cancer, 2(2), 133-134. http://doi.org/10.1038/s43018-021-00178-9
Arbyn, M., Bruni, L., Kelly, D., Basu, P., Poljak, M., Gultekin, M., Bergeron, C., Ritchie, D., & Weiderpass, E. (2020). Tackling cervical cancer in Europe amidst the COVID-19 pandemic. The Lancet. Public health, 5(8), e425. https://doi.org/10.1016/S2468-2667(20)30122-5
Publications
The following is an archive of papers published by the CCGMC since its establishment in 2020. It also includes any publications that have referenced the work of the Consortium.
Freeman, V., Hughes, S., Carle, C., Campbell, D., Egger, S., Hui, H., Yap, S., Deandrea, S., Caruana, M., Onyeka, T., IJzerman, M., Ginsburg, O., Bray, F., Sullivan, R., Aggarwal, A., Peacock, S., Chan, K., Hanna, T., Soerjomataram, I., O’Donnell, D., Steinberg, J., Canfell, K. (2022). Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. Journal of Cancer Policy. https://doi.org/10.1016/j.jcpo.2022.100340
Carle, C., Hughes, S., Freeman, V., Campbell, D., Egger, S., Hui, H., Yap, S., Deandrea, S., Caruana, M., Onyeka, T., IJzerman, M., Ginsburg, O., Bray, F., Sullivan, R., Aggarwal, A., Peacock, S., Chan, K., Hanna, T., Soerjomataram, I., O’Donnell, D., Steinberg, J., Canfell, K. (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: a systematic review of the early evidence. Journal of Cancer Policy. https://doi.org/10.1016/j.jcpo.2022.100338
Sarich, P., Cabasag, CJ., Liebermann, E., Vaneckova, P., Carle, C., Hughes, S., Egger, S., O’Connell, D., Weber, M., Mafra da Costa, A., Caruana, M., Bray, F., Canfell, K., Ginsburg, O., Steinberg, J., Soerjomataram, I.Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. eClinMedicine. https://doi.org/10.1016/j.eclinm.2022.101375
Soerjomataram, I., Bray, F., Lansdorp-Volgelaar, I., Ginsburg, O., Rahal, R., Sullivan, R., Canfell, K. (2022). COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies. Journal of Cancer Policy. https://doi.org/10.1016/j.jcpo.2022.100328
van Wifferen, F., de Jonge, L., Worthington, J., Greuter, M. J. E., Lew, J.-B., Nadeau, C., van den Puttelaar, R., Feletto, E., Yong, J. H. E., Lansdorp-Vogelaar, I., Canfell, K., & Coupé, V. M. H. (2021). Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study. Journal of Medical Screening. https://doi.org/10.1177/09691413211056777
Figueroa JD, Gray E, Pashayan N, et al.(2021) The impact of the Covid-19 pandemic on breast cancer early detection and screening. Preventive Medicine. https://doi.org/10.1016/j.ypmed.2021.106585
Smith MA, Burger EA, Castanon A, de Kok IMCM, Hanley SJB, Rebolj M, Hall MT, Jansen EEL, Killen J, O’Farrell X, Kim JJ, Canfell K. Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis. Preventive Medicine. https://doi.org/10.1016/j.ypmed.2021.106623
Castanon, A., Rebolj, M., Burger, EA., de Kok, I., Smith, MA., Hanley, S., Carozzi, FM., Peacock, S., O’Mahony, JF (2021). Cervical screening during the COVID-19 pandemic: optimising recovery strategies. The Lancet Public Health. https://doi.org/10.1016/S2468-2667(21)00078-5
de Jonge, L., Worthington, J., van Wifferen, F., Iragorri, N., FP Peterse, E., & Lew, JB. et al. (2021). Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. The Lancet Gastroenterology & Hepatology. http://doi.org/10.1016/S2468-1253(21)00003-0
Ginsburg O., Basu P., Kapambwe S., & Canfell K.(2021) Eliminating cervical cancer in the COVID-19 era. Nature Cancer, 2(2), 133-134. http://doi.org/10.1038/s43018-021-00178-9
Arbyn, M., Bruni, L., Kelly, D., Basu, P., Poljak, M., Gultekin, M., Bergeron, C., Ritchie, D., & Weiderpass, E. (2020). Tackling cervical cancer in Europe amidst the COVID-19 pandemic. The Lancet. Public health, 5(8), e425. https://doi.org/10.1016/S2468-2667(20)30122-5